Search Results1-3 of  3

  • YAMASAKI Reishi ID: 9000000607074

    Nagasaki CML Study Group (2009 from CiNii)

    Articles in CiNii:4

    • Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody (2001)
    • Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan (2007)
    • Successful cord blood transplantation for mycosis fungoides (2008)
  • Yamasaki Reishi ID: 9000238053333

    Articles in CiNii:1

    • Distinct Clinical Features of Infectious Complications in Adult T Cell Leukemia/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis in the Nagasaki Transplant Group (2013)
  • Yamasaki Reishi ID: 9000242348086

    Articles in CiNii:1

    • Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: Study by the Nagasaki CML Study Group (2014)
Page Top